MIS: Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery

Sponsor
International Spine Study Group Foundation (Other)
Overall Status
Recruiting
CT.gov ID
NCT04885244
Collaborator
NuVasive (Industry)
500
10
161.1
50
0.3

Study Details

Study Description

Brief Summary

Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients treated with minimally invasive approach, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery rates, and the role of standard work to improve patient outcomes and reduce surgical and postoperative complications.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Index or spine revision surgery for complex adult spinal deformity

Detailed Description

Specific Aims:
  • Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients treated with minimally invasive approach, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery rates, and the role of standard work to improve patient outcomes and reduce surgical and postoperative complications.
  1. Complex ASD patients will be defined based upon clinical, radiographic and/or procedural criteria.
  • Develop and validate a standardized, universal complications classification system for minimally invasive spine surgery

  • Evaluate perioperative blood management approaches, transfusion requirements, including variance in thresholds for blood transfusion and associated complications for minimally invasive adult spinal deformity surgery

  • Evaluate clinical outcomes utilizing legacy patient reported outcome measures (PROMs) including Scoliosis Research Society 22r (SRS 22r) modified Oswestry Disability Index (mODI), Veterans RAND-12 (VR-12), and numeric pain rating scale (NRS), and patient reported outcome measurement information system (PROMIS).

  • Evaluate clinical outcomes stratifying by patient chronological and physiological age

  • Evaluate the cost for episode of care for minimally invasive CADS surgery and cost per QALY gain compared to open surgery for CADS

  • Evaluate the contribution of patient frailty to patient outcomes, cost of care, disability, and complications

  • Evaluate incidence of and risk factors for mental health (MH) compromise among ASD patients treated with MIS techniques, and establish best practice guidelines for assessing MH

  • Evaluate the association of MH with surgical complications, outcomes, hospital length of stay and cost for MIS ASD surgery

  • Evaluate the association of social health surgical complications, outcomes, hospital length of stay and cost for MIS ASD surgery and risk factors for routine (home) discharge vs. skilled nursing facility (SNF)/rehabilitation facility

  • Broaden the evaluation of the minimally invasive surgically treated ASD patient to maximize evaluation of the entirety of the episode of care to include steps that can be taken prior to surgery including "prehabilitation," pain management, and MH care to improve treatment outcomes, reduce cost, reduce hospital length of stay, reduce non-routing discharge and reduce early and late complications

  • Establish a core set of standard work guidelines to clinically and radiographically evaluate and treat ASD patients and evaluate the utility of standard work to improve outcomes for ASD and formulate best practice guidelines for minimally invasive surgical treatment of ASD

  • Evaluate the use of robotic techniques in minimally invasive spine surgery for ASD, and its impact on radiographic parameters and clinical outcomes

  • Evaluate the use of expandable cages in minimally invasive spine surgery for ASD, and its impact on radiographic parameters and clinical outcomes

  • Evaluate the OR efficiency, morbidity of surgery, and cost per episode of care relating to single-position vs. multi-position CADS surgery

  • Evaluate the prevalence and incidence of sacroiliac pain before/after complex adult spinal deformity surgery.

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery (MIS)
Actual Study Start Date :
Jul 28, 2021
Anticipated Primary Completion Date :
Dec 31, 2034
Anticipated Study Completion Date :
Dec 31, 2034

Arms and Interventions

Arm Intervention/Treatment
Operative

Multicenter, prospective, nonrandomized analysis of ASD patients w/diagnosis of congenital, degenerative, idiopathic, neuromuscular, inflammatory or iatrogenic spinal deformity. Participants must be scheduled to have 3 or more levels of Percutaneous posterior spinal instrumentation or 3 level stand alone lateral surgery within next 6 months.

Procedure: Index or spine revision surgery for complex adult spinal deformity
Surgical interventions will be patient specified by treating surgeon.

Outcome Measures

Primary Outcome Measures

  1. Scoliosis Research Society (SRS) 22r [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Scoliosis specific patient reported outcome

  2. Oswestry Disability Index (ODI) [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Spine specific patient reported outcome

  3. Veterans RAND 12 Item Health Survey (VR-12) [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Patient reported outcome

  4. Patient-Reported Outcome Measurement Information System (PROMIS) - Anxiety [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Computer adaptive Patient reported outcome

  5. Patient-Reported Outcome Measurement Information System (PROMIS) - Depression [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Computer adaptive Patient reported outcome

  6. Patient-Reported Outcome Measurement Information System (PROMIS) - Pain Interference [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Computer adaptive Patient reported outcome

  7. Patient-Reported Outcome Measurement Information System (PROMIS) - Physical Function [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Computer adaptive Patient reported outcome

  8. Patient-Reported Outcome Measurement Information System (PROMIS) - Social Satisfaction [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Computer adaptive Patient reported outcome

  9. Patient-Reported Outcome Measurement Information System (PROMIS) - Social Role Satisfaction [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Computer adaptive Patient reported outcome

  10. Radiographic Evaluation [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Cobb angles, Coronal & Sagittal balance, spinopelvic measures

  11. Visual Analog Scale - Back Pain [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Self-reported back pain on scale of 0 (No pain) to 10 (severe pain)

  12. Visual Analog Scale - Leg pain [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]

    Self-reported leg pain on scale of 0 (No pain) to 10 (severe pain)

Secondary Outcome Measures

  1. Edmonton Frail Scale [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]]

    Evaluate frailty on scale of 0 to 17 where higher scores mean more frail

  2. Canadian Study of Health and Aging (CSHA) [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]]

    Frailty scale of 1 to 9; higher scores mean more frail

  3. Adverse Events [Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up]]

    Occurrence of Adverse events meeting reporting criteria and their relationship to intervention throughout the study

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. 18 years of age at the time of treatment 2. Diagnosis of adult congenital, degenerative, idiopathic, neuromuscular, inflammatory or iatrogenic spinal deformity 3. EOS full body or standing 36" AP & Lateral images of entire spine 4. Surgery to be schedule to take place within 6 months (otherwise PROMs/Radiographic images to be recollected) 5. Surgery to include > 3 levels percutaneous posterior spinal instrumentation or 3 level stand-alone lateral 6. And any one of the following:

  1. Radiographic criteria incorporating percutaneous posterior spinal instrumentation: i. PI-LL ≥ 25 degrees ii. Thoracolumbar/lumbar scoliosis ≥ 20 degrees iii. SVA >10cm iv. PT > 30 b. Procedural criteria: i. Single-position surgery ≥ 3 levels fused (Levels=vertebra; S1 is counted as a level; S2 &/or pelvis/ilium is not) ii. Staged ≥ 3 levels fused with percutaneous pedicle screws iii. 3 column osteotomy with percutaneous fixation iv. ACR incorporating open or percutaneous fixation
Exclusion Criteria:
  1. Deformity due to acute trauma

  2. Active spine tumor or infection

  3. Patient is unwilling or unable to complete questionnaires

  4. Women who are pregnant

  5. Prisoners -

Contacts and Locations

Locations

Site City State Country Postal Code
1 Barrow Neurological Institute Phoenix Arizona United States 85013
2 Shiley Center for Orthopaedic Research and Education at Scripps Clinic La Jolla California United States 92037
3 Cedars-Sinai Medical Center Los Angeles California United States 90048
4 University of California - San Francisco Medical Center San Francisco California United States 94143
5 University of Miami Miami Florida United States 33125
6 Rush University, Department of Neurosurgery Chicago Illinois United States 60612
7 Louisiana Spine Institute Shreveport Louisiana United States 71101
8 University of Michigan, Department of Neurosurgery Ann Arbor Michigan United States 48109
9 Duke University Health System Durham North Carolina United States 27710
10 University of Pittsburgh Medical Center Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • International Spine Study Group Foundation
  • NuVasive

Investigators

  • Principal Investigator: Praveen Mummaneni, MD, University of San Francisco
  • Principal Investigator: Paul Park, MD, University of Michigan
  • Principal Investigator: Gregory Mundis, MD, Scripps Clinic, Department of Orthopedic Surgery, La Jolla, CA
  • Principal Investigator: Juan Uribe, MD, Barrow Neurological Institute, Phoenix, AZ

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
International Spine Study Group Foundation
ClinicalTrials.gov Identifier:
NCT04885244
Other Study ID Numbers:
  • 2138
First Posted:
May 13, 2021
Last Update Posted:
Aug 10, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by International Spine Study Group Foundation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 10, 2022